Maria Fe Paz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Maria Fe Paz

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Pharmacogenomics|November 23, 2012

Company profile: labceuticsMark Reis, Maria Fe Paz, Tiffany Olson

Archives of Pathology & Laboratory Medicine|July 26, 2014

Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testingMichael Griffiths, Simon J Patton, Alberto Grossi, et al.

Digital Health|February 27, 2025

Structuring and centralizing breast cancer real-world biomarker data from pathology reports through C-LAB<sup>®</sup> artificial intelligence platformFlorent Le Borgne, Camille Garnier, Camille Morisseau, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylationSara Alvarez, Ramon Diaz-Uriarte, Ana Osorio, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Pharmacogenomics|November 23, 2012

Company profile: labceuticsMark Reis, Maria Fe Paz, Tiffany Olson

Archives of Pathology & Laboratory Medicine|July 26, 2014

Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testingMichael Griffiths, Simon J Patton, Alberto Grossi, et al.

Digital Health|February 27, 2025

Structuring and centralizing breast cancer real-world biomarker data from pathology reports through C-LAB<sup>®</sup> artificial intelligence platformFlorent Le Borgne, Camille Garnier, Camille Morisseau, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylationSara Alvarez, Ramon Diaz-Uriarte, Ana Osorio, et al.

Pageof 1